Increasing Rates of Fluoroquinolone Resistance in Escherichia Coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant Recipients

Fluoroquinolone (FQ) antibiotics have been shown to reduce mortality and the number of febrile episodes when used as prophylaxis during neutropenia. Prior studies suggest that prophylaxis may result in increasing rates of FQ resistance. Fluoroquinolone non-susceptibility trends in Escherichia coli i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauck, Christopher G., Chong, Pearlie P., Miller, Melissa B., Jamieson, Katarzyna, Fine, Jason P., Foster, Matthew C., Shea, Thomas C., van Duin, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167534/
https://www.ncbi.nlm.nih.gov/pubmed/28004038
http://dx.doi.org/10.20411/pai.v1i2.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167534/
https://www.ncbi.nlm.nih.gov/pubmed/28004038
http://dx.doi.org/10.20411/pai.v1i2.115

Ejemplares similares